| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/08/2004 | US20040005563 Detecting transcription products associated urogenital cancers drug screening; drug screening; antiproliferative agents |
| 01/08/2004 | US20040005561 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/08/2004 | US20040005556 Diagnostic tool for use in detecting cancer; immunoassay |
| 01/08/2004 | US20040005553 Comprises membrane protein for treating cancer, inflammation and autoimmune disorders |
| 01/08/2004 | US20040005551 Circulating epstein-barr virus DNA in the serum or plasma of patients for the prediction and detection of epstein-barr virus associated cancers apart from head, neck and lymphoid malignancies |
| 01/08/2004 | US20040005550 Methods and compositions useful for targeting activated vitronectin receptor alphavbeta3 |
| 01/08/2004 | US20040005549 Comprises expression vector capable of efficient replication for use as diagnostic tool in viral gene transfer, propagation, drug screening and vaccine development |
| 01/08/2004 | US20040005547 Using nucleotide sequences primers and probes for diagnosing liver toxicity |
| 01/08/2004 | US20040005545 Plasmid comprising heterologous viral gene sequences for diagnosis, prevention and treatment of respiratory system disorders; vaccine development; viricides |
| 01/08/2004 | US20040005544 Comprise RNA viruses for diagnosis, prevention and treatment of repiratory system disorders; vaccine development; viricides; antisense therapy |
| 01/08/2004 | US20040005543 Compositions and methods for binding agglomeration proteins |
| 01/08/2004 | US20040005540 Apparatus comprising piezoelectric crystals and genetically engineered phage for screening, identifying and detecting ligand affinities for peptides; screening for anthrax, smallpox or toxins in air; biological warfare agents |
| 01/08/2004 | US20040005537 Method of identifying toxic agents using differential gene expression |
| 01/08/2004 | US20040005365 Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same |
| 01/08/2004 | US20040005328 Novel antigens of B. catarrhalis are provided, together with their use in vaccines as well as methods of diagnosing and/or detection. Branhamella catarrhalis (also known as Moraxella catarrhalis) is a gram-negative aerobic bacterium that causes |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005324 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 01/08/2004 | US20040005317 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 01/08/2004 | US20040005313 Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/08/2004 | US20040005299 Method for producing pseudo islets |
| 01/08/2004 | US20040005294 Insulin-like growth factor binding protein expression can be diagnostic of cancer development and progression. |
| 01/08/2004 | US20040004545 Fluid management system |
| 01/08/2004 | US20040004487 Fuel sensor |
| 01/08/2004 | US20040004187 Sucrose monitor |
| 01/08/2004 | US20040004075 High quality, continuous throughput, tissue processing |
| 01/08/2004 | US20040004043 Magnetic separation apparatus and methods |
| 01/08/2004 | US20040003648 Determination of carbon and silicon contents in molten iron |
| 01/08/2004 | DE10226945A1 Feldeffekttransistor auf Basis eines organischen Halbleitermaterials Field-effect transistor based on an organic semiconductor material |
| 01/08/2004 | DE10226675A1 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/08/2004 | DE10226674A1 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/08/2004 | DE10226580A1 Armbanduhr mit Meßfunktion Wristwatch with a measuring function |
| 01/08/2004 | DE10226072A1 Analyseverfahren zur Analyse von spezifischen Bindungsereignissen Analytical methods for analysis of specific binding events |
| 01/08/2004 | DE10226011A1 HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten HTS-capable method and testing system for determining the interaction between c-reactive protein and C-reactive protein binding components |
| 01/08/2004 | DE10225827A1 Messgassonde Gas sample probe |
| 01/08/2004 | DE10225238A1 Socke, Vorrichtung und Verfahren zur Untersuchung der Klimaeigenschaften eines Bekleidungsstücks Sock, apparatus and method for studying the climate characteristics of a garment |
| 01/08/2004 | DE10148112B4 Probennehmer für Schmelzen Samplers for melting |
| 01/08/2004 | CA2542171A1 Modulators and modulation of the interaction between rgm and neogenin |
| 01/08/2004 | CA2530775A1 Method of soil geochemistry analysis prospecting |
| 01/08/2004 | CA2513143A1 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 01/08/2004 | CA2492041A1 Conformational sampling by self-organization |
| 01/08/2004 | CA2491567A1 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 01/08/2004 | CA2491540A1 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 01/08/2004 | CA2491392A1 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 01/08/2004 | CA2491388A1 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2491221A1 Method for determination and/or classification of circulating macrophages and analysis arrangement for carrying out said method |
| 01/08/2004 | CA2491102A1 Assay device for liquid sample |
| 01/08/2004 | CA2491094A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 01/08/2004 | CA2491093A1 Magnetic nanomaterials and methods for detection of biological materials |
| 01/08/2004 | CA2490862A1 Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance |
| 01/08/2004 | CA2490766A1 A system and method for snp genotype clustering |
| 01/08/2004 | CA2490765A1 Nano-sized optical fluorescence labels and uses thereof |
| 01/08/2004 | CA2490367A1 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 01/08/2004 | CA2490283A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | CA2490275A1 System for detecting gas in a wellbore during drilling |
| 01/08/2004 | CA2490261A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | CA2489675A1 Glycoalkaloid compositions and various uses thereof |
| 01/08/2004 | CA2489520A1 A method for the detection of apoptosis |
| 01/08/2004 | CA2489294A1 A screening method and compounds for treating friedreich ataxia |
| 01/08/2004 | CA2488659A1 Method, device and system for detecting the presence of microorganisms |
| 01/08/2004 | CA2488371A1 Assay for detecting an analyte containing or labelled with a haem moiety |
| 01/08/2004 | CA2487824A1 Oncolytic viruses as phenotyping agents for neoplasms |
| 01/08/2004 | CA2487336A1 Automatic differentiation of a sample solution and a control solution |
| 01/07/2004 | EP1378753A1 A screening method and compounds for treating Friedreich Ataxia |
| 01/07/2004 | EP1378752A1 Method of quantifying antigen expression |
| 01/07/2004 | EP1378750A1 Blood analyzers and methods for analyzing blood |
| 01/07/2004 | EP1378749A1 Screening method |
| 01/07/2004 | EP1378748A1 Method and device for discriminating between real and fake gemstones based on electrical conductivity measurements |
| 01/07/2004 | EP1378747A2 Optical sensor |
| 01/07/2004 | EP1378744A1 Sugar monitor |
| 01/07/2004 | EP1378743A2 Apparatus for spectrometrically measuring isotopic gas |
| 01/07/2004 | EP1378742A2 Device for withdrawing samples |
| 01/07/2004 | EP1378576A1 Storing and detecting nucleic acid administered to a solid carrier |
| 01/07/2004 | EP1378575A1 Method of detecting inorganic phosphoric acid, pyrophosphoric acid and nucleic acid and method of typing snp sequence of dna |
| 01/07/2004 | EP1378571A1 5' ESTs for secreted proteins expressed in various tissues |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378525A2 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378521A1 Anti-Carbohydrate Deficient Transferrin (CDT) spezific antibody, its production and use |
| 01/07/2004 | EP1378518A1 RGS2 as a biomarker for macrophage activation and for activated-macrophage-related disorder |
| 01/07/2004 | EP1378517A1 Phosphoinositolglycan (PIG) binding protein from adipocytes |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1378242A1 Methods and compositions for the stabilization of brain natriuretic peptide (BNP) in blood samples |
| 01/07/2004 | EP1377837A1 Array-based biomolecule analysis |
| 01/07/2004 | EP1377836A2 Method and apparatus for detecting response to damage and diagnostic method therefor |
| 01/07/2004 | EP1377835A2 Method for assaying flowing media for microbial toxins |
| 01/07/2004 | EP1377834A2 Medicaments which are modulators of hm74 and/or hm74a activity |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377832A2 Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases |
| 01/07/2004 | EP1377831A2 Multiple analyte assaying device with a multiple sample introduction system |
| 01/07/2004 | EP1377830A2 Arrays for determining binding of biomolecules |
| 01/07/2004 | EP1377829A2 Intracellular analysis |
| 01/07/2004 | EP1377828A2 Methods of analysis and labeling of protein-protein interactions |
| 01/07/2004 | EP1377827A2 Method for determining analyte molecules in a sample |
| 01/07/2004 | EP1377826A2 Opiate receptors |
| 01/07/2004 | EP1377824A1 Indicator for calcium and magnesium |
| 01/07/2004 | EP1377823A1 Automated immunohistochemical and in situ hybridzation assay formulations |
| 01/07/2004 | EP1377819A1 Method and device for monitoring and controlling a process |
| 01/07/2004 | EP1377815A2 Biological measurement system |